11.09
-0.62
(-5.29%)
At close: January 10 at 5:29:55 PM GMT+1
Key Executives
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Jeppe Ovli Ovlesen EE, MBA | CEO & Director | 3.66M | -- | 1962 |
| Mr. Bjorn Westberg | Chief Financial Officer | -- | -- | 1962 |
| Dr. Thomas Boesen Ph.D. | Chief Operating Officer | -- | -- | -- |
| Mr. James Knight M.B.A. | Chief Business Officer | -- | -- | -- |
| Ms. Kristen Harting M.D. | Chief Medical Officer | -- | -- | -- |
SynAct Pharma AB
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 5
Description
SynAct Pharma AB, a clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden. The company develops AP1189, a drug candidate in Phase 2 clinical trial for the treatment of rheumatoid arthritis, idiopathic membranous nephropathy, and virus-induced respiratory insufficiency. It is developing TXP-11, an advanced peptide agonist that is in preclinical trials for the prevention of organ failure in surgery; and various drug programs to treat auto-immune and inflammatory diseases. SynAct Pharma AB was founded in 2012 and is headquartered in Lund, Sweden.
Corporate Governance
SynAct Pharma AB’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
6YX0.F Lobe Sciences Ltd.
0.0105
+16.67%
4YL.F Nanoform Finland Oyj
1.2720
-2.90%
ONCOZ.ST OncoZenge AB (publ)
3.7650
+9.29%
IRLAB-A.ST IRLAB Therapeutics AB (publ)
9.98
-4.50%
ELIC.ST Elicera Therapeutics AB (publ)
1.9900
-5.24%
CANTA.ST Cantargia AB (publ)
1.7010
+0.06%
SANION.ST Saniona AB (publ)
6.80
-3.00%
EGTX.ST Egetis Therapeutics AB (publ)
6.30
-7.35%
XSPRAY.ST Xspray Pharma AB (publ)
29.25
-15.34%
ACE.ST Ascelia Pharma AB (publ)
2.9850
+10.15%